Clinician- and Patient-Reported Outcomes with Tirbanibulin 1% Treatment for Actinic Keratosis in Routine Clinical Practice Across the U.S. (PROAK Study). J of Skin [Internet]. 2023 May 20 [cited 2025 Jun. 15];7(3):771-87. Available from: https://skin.dermsquared.com/skin/article/view/2140